Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mirko Manchia, Federica Marmo, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Gut Bacteria and Neurotransmitters
Leon M. T. Dicks
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1838-1838
Open Access | Times Cited: 223
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6460-6501
Open Access | Times Cited: 59
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 52
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 40
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Andrea de Bartolomeis, Licia Vellucci, Mark C. Austin, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 909-909
Open Access | Times Cited: 30
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 18
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 975-975
Open Access | Times Cited: 17
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Kah Kheng Goh, Tzu‐Hua Wu, Chun-Hsin Chen, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 3, pp. 236-252
Closed Access | Times Cited: 41
Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine–Glutamate Crosstalk
Luca Raiteri
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1518-1518
Open Access | Times Cited: 5
The SLC6A15–SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance
Jędrzej Kukułowicz, Krzysztof Pietrzak-Lichwa, Klaudia Klimończyk, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 142-193
Open Access | Times Cited: 12
Salivary Metabolomics Reveals that Metabolic Alterations Precede the Onset of Schizophrenia
Gaoping Cui, Ying Qing, Minghui Li, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 11, pp. 5010-5023
Closed Access | Times Cited: 26
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 2035-2052
Closed Access | Times Cited: 19
Novel Treatments for Schizophrenia
Steven M. Paul, Alan Breier
Oxford University Press eBooks (2025), pp. 231-246
Closed Access
Molecular investigation of ergot alkaloid ergotamine's modulatory effects on glycine receptors expressed in Xenopus oocytes
Sanung Eom, Minsu Pyeon, Myungmi Moon, et al.
Computational and Structural Biotechnology Journal (2025)
Open Access
Editorial to the Special Issue “Glycine-(and D-Serine)-Related Neurotransmission: Promising Therapeutic Targets with Still Unsolved Problems”
Luca Raiteri
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1140-1140
Open Access
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Intermittent fasting alerts neurotransmitters and oxidant/antioxidant status in the brain of rats
Mona Abdel-Rahman, Aida A. Hussein, Omar A. Ahmed‐Farid, et al.
Metabolic Brain Disease (2024)
Open Access | Times Cited: 3
Glycine Receptor Endocytosis and Signaling
M. Saad, Dhruv Kumar
˜The œReceptors (2025), pp. 223-233
Closed Access
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Giuseppe De Simone, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 574-574
Open Access | Times Cited: 8
Anger management: Mechanisms of glutamate receptor-mediated synaptic plasticity underlying animal aggression
Jacob C. Nordman
The International Journal of Biochemistry & Cell Biology (2021) Vol. 142, pp. 106120-106120
Open Access | Times Cited: 18
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome
Antonella Gagliano, Federica Murgia, Agata Maria Capodiferro, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6493-6493
Open Access | Times Cited: 12
Integration of proteinogenic amino acids in the pathogenesis of schizophrenia
Michelle S. Carvalho, Maurício L. Sforça, Silvana A. Rocco, et al.
Medicine Advances (2024) Vol. 2, Iss. 2, pp. 123-135
Open Access | Times Cited: 2
Nutritional Psychiatry: The Present State of the Evidence
Mohamed Baklola
(2024), pp. 485-505
Closed Access | Times Cited: 2
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
Imane Frouni, Sébastien Belliveau, Shawn P. Maddaford, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174452-174452
Closed Access | Times Cited: 14
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
Marta Matrone, Georgios D. Kotzalidis, Andrea Romano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 114, pp. 110493-110493
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top